News Archives - Page 4 of 4

Kelun and Ellipses Announce a Licensing Agreement for A400

Suzanne Wood | 26 March 2021

Kelun and Ellipses Announce a Licensing Agreement for A400 Kelun-Biotech and Ellipses Pharma Announce a Licensing Agreement for A400 Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. and UK company Ellipses Pharma Ltd. Announce a Licensing Agreement for Innovative Small Molecule Cancer Therapeutics Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. (hereinafter referred to as “Kelun-Biotech”), a subsidiary of Sichuan Kelun [...]

Resistance-Busting ICR Drug Enters Clinical Trial

Suzanne Wood | 19 March 2021

Resistance-Busting ICR Drug Enters Clinical Trial Resistance-busting ICR drug enters clinical trial A drug discovered at The Institute of Cancer Research, London, that could counteract drug resistance in patients with cancers including acute myeloid leukaemia has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust. The drug, now called EP0042, is [...]